Cholesterol Guidelines Look High And Low: Statin Market Extended At Both Ends
This article was originally published in The Pink Sheet Daily
Executive Summary
In shifting away from specific targets and non-statin add-on therapies, new ACC/AHA cholesterol guidelines support treatment of people at relatively low risk for events and more intensive therapy for those at higher risk.